Long non-coding RNA GAS5 Functions as a tumor suppressor in renal cell carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 1077-1082

  Qiao, Hui Ping ^a,b   Gao, Wei Shi ^c   Huo, Jian Xin ^b   Yang, Zhan Shan ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b BAOTOU MEDICAL COLLEGE   (China)

^c Inner Mongolia Autonomous Region Hospital   (China)

Author keywords

GAS5; Long non coding RNAs; Renal cell carcinoma

Indexed keywords

GAS5 LONG NON CODING RNA, HUMAN; GAS5 LONG NON-CODING RNA, HUMAN; LONG UNTRANSLATED RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; APOPTOSIS; CARCINOMA, RENAL CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA, LONG NONCODING;

EID: 84877683011     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.1077     Document Type: Article

References (34)

1. Amit D, Hochberg A (2010). Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. J Transl Med, 8, 134.
2. Birney E, Stamatoyannopoulos JA, Dutta A, et al (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.
3. Cho IC, Chung J (2012). Current status of targeted therapy for advanced renal cell carcinoma. Korean J Urol, 53, 217-28.
4. Chow WH, Devesa SS, Warren JL, Fraumeni JF, Jr. (1999). Rising incidence of renal cell cancer in the United States. JAMA, 281, 1628-31.
5. Gibb EA, Brown CJ, Lam WL (2011). The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 10, 38.
6. Gutschner T, Diederichs S (2012). The Hallmarks of Cancer: A long non-coding RNA point of view. RNA Biol, 9, 703-19.
7. Hasenpusch G, Pfeifer C, Aneja MK, et al (2011). Aerosolized BC-819 inhibits primary but not secondary lung cancer growth. PLoS One, 6, e20760.
8. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006). Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst, 98, 1331-4.
9. Huarte M, Rinn JL (2010). Large non-coding RNAs: missing links in cancer? Hum Mol Genet, 19, R152-61.
10. Ito S, Koshikawa N, Mochizuki S, Takenaga K (2007). 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol, 31, 261-8.
11. Janzen NK, Kim HL, Figlin RA, Belldegrun AS (2003). Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am, 30, 843-52.
12. Kapranov P, St Laurent G, Raz T, et al (2010). The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol, 8, 149.
13. Liang P, Pardee AB (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-71.
14. Linehan WM, Walther MM, Alexander RB, Rosenberg SA (1993). Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute. Semin Urol, 11, 41-3.
15. Ljungberg B, Campbell SC, Choi HY, et al (2006). The epidemiology of renal cell carcinoma. Eur Urol, 60, 615-21.
16. Mercer TR, Dinger ME, Mattick JS (2009). Long non-coding RNAs: insights into functions. Nat Rev Genet, 10, 155-9.
17. Mevorach RA, Segal AJ, Tersegno ME, Frank IN (1992). Renal cell carcinoma: incidental diagnosis and natural history: review of 235 cases. Urology, 39, 519-22.
18. Mizrahi A, Czerniak A, Levy T, et al (2009). Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med, 7, 69.
19. Morrison LE, Jewell SS, Usha L, et al (2007). Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer, 46, 397-405.
20. Mourtada-Maarabouni M, Hasan AM, Farzaneh F, Williams GT (2010). Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5). Mol Pharmacol, 78, 19-28.
21. Mourtada-Maarabouni M, Pickard MR, Hedge VL,et al (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene, 28, 195-208.
22. Muller AJ, Chatterjee S, Teresky A, Levine AJ (1998). The gas5 gene is disrupted by a frameshift mutation within its longest open reading frame in several inbred mouse strains and maps to murine chromosome 1. Mamm Genome, 9, 773-4.
23. Nie L, Wu HJ, Hsu JM, et al (2012). Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res, 4, 127-50.
24. Nupponen NN, Carpten JD (2001). Prostate cancer susceptibility genes: many studies, many results, no answers. Cancer Metastasis Rev, 20, 155-64.
25. Raho G, Barone V, Rossi D, et al (2000). The gas 5 gene shows four alternative splicing patterns without coding for a protein. Gene, 256, 13-7.
26. Schneider C, King RM, Philipson L (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-93.
27. Sidi AA, Ohana P, Benjamin S, et al (2008). Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J Urol, 180, 2379-83.
28. Smaldone MC, Davies BJ (2010). BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther, 12, 607-16.
29. Smedley D, Sidhar S, Birdsall S,et al (2000). Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer, 28, 121-5.
30. Smith CM, Steitz JA (1998). Classification of gas5 as a multismall-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol, 18, 6897-909.
31. Soto-Vega E, Arroyo C, Richaud-Patin Y, et al (2009). P-glycoprotein activity in renal clear cell carcinoma. Urol Oncol, 27, 363-6.
32. Tsai MC, Spitale RC, Chang HY (2011). Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res, 71, 3-7.
33. van Spronsen DJ, Mulders PF, De Mulder PH (2005). Novel treatments for metastatic renal cell carcinoma. Crit Rev Oncol Hematol, 55, 177-91.
34. Wilusz JE, Sunwoo H, Spector DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 23, 1494-504.